EdwardMPeresMD

Hematology • Detroit, MI

Hematologic Oncology

Associate Professor Hematology Oncology Stem CellTransplant, Cellular Therapy Internal Medicine, Henry Ford Hospital Wayne State Universty

Join to view full profile

Dr. Peres is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Peres' full profile

Already have an account?

Office
2799 W Grand Blvd
Ste K13
Detroit, MI 48202
Phone+1 313-916-5002

Education & Training

Detroit Medical CenterBone Marrow Transplant , 2003 - 2004
Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 2000 - 2003
Children's Hospital of MichiganResidency, Pediatrics, 1997 - 2000
Ross University School of MedicineClass of 1997

Certifications & Licensure

MI State Medical License 2000 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
Trial Of Double Umbilical Cord Blood Transplantation Start of enrollment: 2008 Dec 01
Completed
Phase 2
Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies Start of enrollment: 2010 Nov 01
Completed
Phase 1, Phase 2
Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease Start of enrollment: 2018 Dec 23
Terminated
Phase 3
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation Start of enrollment: 2020 Feb 04
Recruiting
Phase 1, Phase 2
Roles: Contact, Sub-Investigator
Join now to see all

Publications & Presentations

PubMed

10 citations
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant
Scott R. Solomon, Andrew St. Martin, Mei-Jie Zhang, Karen K. Ballen, Asad Bashey
Biology of Blood and Marrow Transplantation. 2020-10-01
1 citations
Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy.
Shatha Farhan, Michael Bazydlo, Klodiana Neme, Nancy Mikulandric, Edward Peres
Advances in Hematology. 2017-11-08
198 citations
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
Lori Muffly, Marcelo C. Pasquini, Michael Martens, Ruta Brazauskas, Xiaochun Zhu
Blood. 2017-08-31

Press Mentions

Henry Ford Cancer Institute Treats Its First Patient with Innovative 'Living Drug' TherapyJune 18th, 2019

Professional Memberships

American Society of Hematology - ASH
Member